Wednesday, November 01, 2006

Cyborgs don't have to go blind: / Implantable Telescopes! More good news on the Age-Related Macular Degeneration front

VisionCare Ophthalmic Technologies, Inc. :: Results of Implantable Telescope Trial Published in Ophthalmology Report / Ion Vision and Quality of Life in Patients With End-Stage Age-Related Macular Degeneration: "'Implantable Miniature Telescope for the Treatment of Visual Acuity Loss Resulting from End-Stage Age-Related Macular Degeneration,' details the results from the IMT002 trial which enrolled 217 patients at 28 U.S. investigational sites. Patients entering the trial had severe vision loss due to the characteristic central blind spot caused by end-stage macular degeneration. The publication reports 90% of patients met or exceeded the protocol-specified primary efficacy endpoint of visual improvement, defined as a 2-line gain in either distance or near vision on the study eye chart. The protocol stated the endpoint would be achieved if at least 50% of patients met this target"


Post a Comment

<< Home